Introduction
Iltauf L is a prescription medication that contains two active ingredients: Levosulpiride and Ilaprazole. Levosulpiride is a dopamine receptor antagonist, while Ilaprazole belongs to a class of medications called proton pump inhibitors. Iltauf L is primarily used in the management of certain gastrointestinal disorders.
Uses
Iltauf L is commonly prescribed for the treatment of conditions such as gastroesophageal reflux disease (GERD), functional dyspepsia, and gastroparesis. It helps to relieve symptoms such as heartburn, acid reflux, bloating, and discomfort in the stomach.
Dosage and Administration
The dosage of Iltauf L may vary depending on the specific condition being treated and individual patient factors. Follow the instructions provided by your healthcare provider. Generally, the recommended dose is one capsule taken orally once daily, preferably before a meal. Swallow the capsule whole with a glass of water. Do not crush or chew the capsule.
Mechanism of Action
Levosulpiride, one of the active ingredients in Iltauf L, acts as a dopamine receptor antagonist. It works by blocking the receptors in the brain that dopamine would normally bind to, which helps to regulate the levels of dopamine in certain areas of the brain. Ilaprazole, on the other hand, is a proton pump inhibitor that reduces the production of stomach acid by inhibiting the enzyme responsible for acid secretion.
Side Effects
Common side effects may include dry mouth, dizziness, headache, and gastrointestinal disturbances such as nausea, diarrhea, or constipation. If any of these side effects persist or worsen. Inform your healthcare provider.
In rare cases, Iltauf L may cause more serious side effects, such as allergic reactions, abnormal heart rhythms, or movement disorders. If you experience any unusual or severe symptoms, seek immediate medical attention.
Drug Interactions
Iltauf L may interact with other medications, including certain antidepressants, antipsychotics, and medications that affect the heart rhythm. Inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, and herbal products, to avoid potential interactions.
Precautions
Before taking Iltauf L, inform your healthcare provider about any pre-existing medical conditions, allergies, or medications you are currently taking. This medication may not be suitable for individuals with a history of certain heart conditions, movement disorders, or hypersensitivity to any of the ingredients. Avoid alcohol consumption while taking Iltauf L, as it may increase the risk of side effects.
Storage
Patient Tips
- Take Iltauf L exactly as prescribed by your healthcare provider. Do not exceed the recommended dose.
- maintain a healthy lifestyle, including a balanced diet and regular exercise, to optimize the effectiveness of the medication.
- If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule.
- If you have any concerns or questions about your treatment with Iltauf L, do not hesitate to consult your healthcare provider.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Levosulpiride (International database) (Drugs.com) [Accessed 7 Jun. 2024] (online) Available at:
- Savarino E, Ottonello A, Martinucci I, Dulbecco P, Savarino V. Ilaprazole for the treatment of gastro-esophageal reflux. Expert Opin Pharmacother. 2016 Oct;17(15):2107-13. doi: 10.1080/14656566.2016.1232389. Epub 2016 Sep 12. [Accessed 26 Jun. 2024] Available at:
- Mepenzolate (Professional Patient Advice) Professional Information (A-Z Drug Facts) (Drugs.com) [Accessed 21 Jun. 2024] (online) Available at:
- Bohidar NP, Krishna K, Panda BK, Patel C. Ilaprazole: Is this a superior proton pump inhibitor for duodenal ulcer? Trop Gastroenterol. 2013 Apr-Jun;34(2):95-8. doi: 10.7869/tg.2012.105. [Accessed 27 Jun. 2024] Available at:
Reviews
There are no reviews yet.